These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 17481626)

  • 1. An ectopic pregnancy masked by follicular initiation of gonadotropin-releasing hormone agonist for pituitary desensitization prior to in vitro fertilization.
    Hemmings R; Biljan MM; Dean N; Tan SL
    J Assist Reprod Genet; 1998 Mar; 15(3):161-3. PubMed ID: 9547694
    [No Abstract]   [Full Text] [Related]  

  • 2. Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos.
    Takeuchi K; Orita Y; Iwakawa T; Kuwatsuru Y; Kuroki Y; Fukumoto Y; Mizobe Y; Tokudome M; Moewaki H
    Front Endocrinol (Lausanne); 2023; 14():1277873. PubMed ID: 38027155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation protocols for poor ovarian responders: a network meta-analysis of randomized controlled trials.
    Di M; Wang X; Wu J; Yang H
    Arch Gynecol Obstet; 2023 Jun; 307(6):1713-1726. PubMed ID: 35689674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.
    Yang S; Liu N; Li Y; Zhang L; Yue R
    Arch Gynecol Obstet; 2021 Feb; 303(2):347-362. PubMed ID: 33236173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: An RCT.
    Davar R; Neghab N; Naghshineh E
    Int J Reprod Biomed; 2018 Apr; 16(4):255-260. PubMed ID: 29942933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing
    Lee H; Choi HJ; Yang KM; Kim MJ; Cha SH; Yi HJ
    Obstet Gynecol Sci; 2018 Jan; 61(1):102-110. PubMed ID: 29372156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.
    Cakmak H; Tran ND; Zamah AM; Cedars MI; Rosen MP
    Fertil Steril; 2014 May; 101(5):1308-14. PubMed ID: 24636401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.
    Chang EM; Han JE; Won HJ; Kim YS; Yoon TK; Lee WS
    J Assist Reprod Genet; 2012 Mar; 29(3):225-30. PubMed ID: 22160464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol.
    Chang HJ; Lee JR; Jee BC; Suh CS; Kim SH
    J Korean Med Sci; 2009 Apr; 24(2):262-8. PubMed ID: 19399268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gonadotropin-releasing hormone antagonists in poor responders.
    Mahutte NG; Arici A
    Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders.
    Dragisic KG; Davis OK; Fasouliotis SJ; Rosenwaks Z
    Fertil Steril; 2005 Oct; 84(4):1023-6. PubMed ID: 16213865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimizing ovarian stimulation for IVF using GnRH antagonists].
    Kolibianakis EM
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S42-5. PubMed ID: 15643688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder.
    Frankfurter D; Dayal M; Dubey A; Peak D; Gindoff P
    Fertil Steril; 2007 Nov; 88(5):1442-5. PubMed ID: 17481626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ongoing pregnancy from two waves of follicles developing during a long follicular phase of the same cycle.
    Bentov Y; Esfandiari N; Gokturk A; Burstein E; Fainaru O; Casper RF
    Fertil Steril; 2010 Jun; 94(1):350.e8-11. PubMed ID: 20138269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.
    Chung K; Krey L; Katz J; Noyes N
    Fertil Steril; 2005 Aug; 84(2):313-8. PubMed ID: 16084870
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.